The United States Court of Appeals for the Third Circuit has held that disclosure of common ingredients and clinical substantiation of performance claims or disclosure that certain claims are open to substantial question in the medical community are reasonable requirements to counter the effects of extensive advertising found to violate the Federal Trade Commission Act.
American Home Products Corp. v. FTC, 695 F.2d 681 (3d Cir. 1982).
Dale E. Walker,
Administrative Law - Federal Trade Commission - Deceptive Advertising - Disclosure and Substantiation Requirements - Over-the-Counter Internal Analgesics,
Duq. L. Rev.
Available at: https://dsc.duq.edu/dlr/vol22/iss1/11